BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...

Growth driven by demand for natural, clean-label foods, the sector is seeing robust expansion, particularly in emerging economies. Notably, the beverage application segment is experiencing significant ...

Gain, the go-to detergent known for spreading joy through long-lasting, irresistible scents is turning up the fragrance, freshness, and cleansing power with the introduction of Gain Plus—so consumers ...

From gentle enzyme powders and beginner-friendly PHAs to luxe peels and sensory scrubs, Helen McGurk rounds up the next-generation exfoliants for fresh, glowing skin ...

Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, ...

BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...

Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...

The chondrosarcoma market is anticipated to increase during the forecast period (2026--2036), owing to improved diagnosis, treatment advancements, increased awareness, the launch of emerging therapies ...

The new WHO guidance strengthens the fight against Plasmodium vivax malaria by combining safer radical cure medicines with routine G6PD testing to prevent dangerous side effects. By clearing both ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced the launch of its Early Access Express License, a new licensing option designed to support early stage innovators at ...

Uncover a North Georgia steakhouse where mountain views set the scene for dry aged perfection, bold flavors, and an ...